Catalyst Wire Dossier Catalyst Wire Dossier

Selective JAK inhibitor

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Selective JAK inhibitor, covering 2025-01-06 to 2025-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Use of Selective JAK Inhibitor in ILD and Skin Tightness of Systemic Sclerosis Versus MMF [Phase 3]

See pricing